BioNTech to showcase data-rich lung cancer pipeline at ELCC 2026
Compartilhar
BioNTech (NASDAQ:BNTX) announced today its comprehensive participation in the European Lung Cancer Congress (ELCC) 2026, where the company will present updated data across its diversified lung cancer portfolio.
